Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/44460
Title: The essential role of prevention in reducing the cancer burden in Europe: a commentary from Cancer Prevention Europe.
Authors: Espina, C
Bauld, L
Bonanni, B
Brenner, H
Brown, K
Dillner, J
Kampman, E
Nilbert, M
Vineis, P
Weijenberg, MP
Cox, A
de Kok, TM
Fecht, D
Mitrou, G
Muller, DC
Serrano, D
Steindorf, K
Storm, H
Thorat, MA
van Duijnhoven, F
Weiderpass, E
Schüz, J
First Published: 17-May-2019
Publisher: SAGE Publications (UK and US), Italian Association of Radiation Oncology (AIRO) [Associate Organisation] 2. Italian Cancer Society (SIC), Italian Society of Surgical Oncology (SICO)
Citation: Tumori, 2019
Abstract: [First paragraph] The potential of cancer prevention In 28 out of 40 United Nations–defined European countries, cancer is now the leading cause of premature death, and the second most common in the other 12, with a total of 1.93 million deaths and 3.91 million new incident cases in 2018.1 Those numbers are projected to rise to 2.55 million deaths and 4.75 million incident cases in Europe by 2040, as a result of population aging and growth, representing an overall increase in number of deaths by 32%.2 Notably, however, these estimates are based on prediction models taking current incidence rates and time trends into consideration, so that preventive actions taken today could change this forecast, i.e., lead to lower than those expected numbers. The cancer cost in 27 countries in the European Union in 2009 was €126 billion, 60% incurred in nonhealthcare areas, with almost €43 billion in lost productivity due to early death. Of the 4 cancers studied, lung cancer had the highest economic burden.3
DOI Link: 10.1177/0300891619851865
eISSN: 2038-2529
Links: https://journals.sagepub.com/doi/10.1177/0300891619851865
http://hdl.handle.net/2381/44460
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © the authors, 2019. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium non-commercially, provided the original author and source are credited.
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
File Description SizeFormat 
0300891619851865.pdfPublished (publisher PDF)176.01 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.